MENU
+Compare
NNCSF
Stock ticker: OTC
AS OF
Oct 6 closing price
Price
$2.90
Change
+$0.05 (+1.75%)
Capitalization
827.01M

NNCSF Nanosonics Ltd. Forecast, Technical & Fundamental Analysis

Nanosonics is largely a single-product firm, and its Trophon device provides high-level disinfection of ultrasound probes used in semicritical procedures... Show more

NNCSF
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for NNCSF with price predictions
Feb 03, 2026

NNCSF sees its 50-day moving average cross bearishly below its 200-day moving average

The 50-day moving average for NNCSF moved below the 200-day moving average on January 12, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for NNCSF moved out of overbought territory on February 02, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 18 similar instances where the indicator moved out of overbought territory. In of the 18 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Momentum Indicator moved below the 0 level on February 02, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on NNCSF as a result. In of 49 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

NNCSF moved below its 50-day moving average on February 02, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for NNCSF crossed bearishly below the 50-day moving average on January 13, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In of 17 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

NNCSF broke above its upper Bollinger Band on January 29, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 42 cases where NNCSF's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for NNCSF just turned positive on January 29, 2026. Looking at past instances where NNCSF's MACD turned positive, the stock continued to rise in of 38 cases over the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 101 cases where NNCSF Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. NNCSF’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.195) is normal, around the industry mean (11.448). P/E Ratio (53.732) is within average values for comparable stocks, (149.436). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.437). NNCSF has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.017). P/S Ratio (5.583) is also within normal values, averaging (111.001).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. NNCSF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
NNCSF
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
N/A
Address
7-11 Talavera Road
Phone
+61 280631600
Employees
482
Web
https://www.nanosonics.com.au
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FESAX12.710.10
+0.79%
First Eagle Small Cap Opportunity A
LVAMX10.06-0.03
-0.30%
LSV US Managed Volatility Investor
PVCMX12.36-0.05
-0.40%
Palm Valley Capital Investor
PCLCX15.87-0.27
-1.67%
PACE Large Co Growth Equity P
EGFFX24.67-1.25
-4.82%
Edgewood Growth Retail

NNCSF and Stocks

Correlation & Price change

A.I.dvisor tells us that NNCSF and ASAPF have been poorly correlated (+21% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NNCSF and ASAPF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NNCSF
1D Price
Change %
NNCSF100%
N/A
ASAPF - NNCSF
21%
Poorly correlated
-6.05%
NHNKY - NNCSF
8%
Poorly correlated
+1.43%
NHNKF - NNCSF
0%
Poorly correlated
N/A
NVYTF - NNCSF
0%
Poorly correlated
N/A
MRCHF - NNCSF
0%
Poorly correlated
N/A
More

Groups containing NNCSF

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NNCSF
1D Price
Change %
NNCSF100%
N/A
Pharmaceuticals: Other
industry (107 stocks)
4%
Poorly correlated
-0.87%
Pharmaceuticals
industry (380 stocks)
0%
Poorly correlated
+27.23%